key: cord-0749512-oap5064x
authors: Nikniaz, Zeinab; Somi, Mohammad Hossein; Dinevari, Masood Faghih; Taghizadieh, Ali; Mokhtari, Leila
title: Diabesity Associates with Poor COVID-19 Outcomes among Hospitalized Patients
date: 2021-06-30
journal: J Obes Metab Syndr
DOI: 10.7570/jomes20121
sha: 3cb107ccce7668528df566cd0baad9f9138eaa23
doc_id: 749512
cord_uid: oap5064x

BACKGROUND: Although numerous studies have investigated obesity’s negative effect on coronavirus disease 2019 (COVID-19) outcomes, only a limited number focused on this association in diabetic patients. In this study, we analyzed the association between obesity and COVID-19 outcome (death, intensive care unit [ICU] admission, mechanical ventilation needs, quick Sequential Organ Failure Assessment [qSOFA] score, and confusion, urea, respiratory rate, blood pressure [CURB-65] scores) for hospitalized diabetic patients. METHODS: In this prospective hospital-based registry of patients with COVID-19 in East Azerbaijan, Iran, 368 consecutive diabetic patients with COVID-19 were followed from admission until discharge or death. Self-reported weight and height were used to calculate body mass index (kg/m(2)) upon admission. Our primary endpoint was analyzing obesity and COVID-19 mortality association. Assessing the associations among obesity and disease severity, ICU admission, and mechanical ventilation was our secondary endpoint. RESULTS: We analyzed data from 317 patients and found no significant difference between obese and non-obese patients regarding frequency of death, invasive mechanical ventilation, ICU admission, CURB-65, or qSOFA scores (P>0.05). After adjusting for confounding factors, obese diabetic COVID-19 patients were 2.72 times more likely to die than non-obese patients. Moreover, ventilator dependence (adjusted odds ratio [aOR], 1.87; 95% confidence interval [CI], 1.03–4.76) and ICU admission (aOR, 2.41; 95% CI, 1.11–5.68) odds were significantly higher for obese patients than non-obese patients. CONCLUSION: The results of the present study indicated that obesity worsens health outcomes for diabetic COVID-19 patients.

The coronavirus disease 2019 (COVID-19) outbreak originated in Wuhan, China, spread rapidly, and was declared a global pandemic in March 2020. In Iran, the first official COVID-19 death was February 19, 2020. Between then and August 4, 2020, approximately 312,035 more cases have been diagnosed. 1 COVID-19 is associated with high morbidity and mortality rates 2 and a 6.0% global fatality rate. 3 In Iran, there is a 24.4% 30-day cumulative risk for in-hospital mortality 4 with a 3.6% average COVID-19 mortality rate. 5 Different factors affect COVID-19's morbidity and mortality contributors. 9 Obesity is a risk factor for infectious diseases such as pneumonia, surgical-site infections, nosocomial infections, periodontitis and skin infections. 10 Numerous studies have also shown obesity's negative effect on COVID-19 severity and critical conditions. 3, 11, 12 Mechanisms such as increased proinflammatory cytokines, decreased immunity and decreased lung function may play a role in poor COVID-19 health outcomes among obese patients. 13 In addition, obesity may contribute to the COVID-19 health outcomes in patients with underlying diseases such as diabetes mellitus. Diabetic patients often have impaired immune function, low-grade chronic systemic inflammation, and impaired lung function. [14] [15] [16] This is similar to the comorbidities observed in obese patients. In this study, we postulated that obese diabetic patients with COVID-19 may have worse disease outcomes than non-obese diabetic patients. There have been few studies on the relationship between obesity and COVID-19 outcomes in diabetic patients. In this study, we analyzed the association between obesity and COV- For data collection, a questionnaire that included demographic characteristics, vital signs, drug history, laboratory parameters, CO-VID-19-related symptoms, medication, and outcomes was designed. We also collected lifestyle information such as smoking and physical activity levels. During anamnesis, we collected information on comorbidity diagnoses. The COVID-19 nurses completed the questionnaires and a trained researcher transferred the information to the statistical software. We ascertained diabetes mellitus status through self-reporting.

The patients were followed until they were discharged. Trained nurses recorded all clinical and laboratory parameters daily. Body mass index (BMI; kg/m 2 ) was calculated using self-reported weight and height upon hospital admission. We considered a person with a BMI higher than 30 kg/m 2 to be obese. In the AzarCoRe, approximately 338 diabetic patients registered at Imam Reza Hospital. Twenty-one patients did not complete the questionnaire's request for anthropometric information or disease outcomes, so we only analyzed data from 317 patients.

Tabriz University of Medical Sciences' Ethics Committee approved this study (Ethics code: IR.TBZMED.REC.1398.1274). Informed consent was obtained from the patients or their next of kin.

The primary endpoint of this study was analyzing the association between obesity and mortality from COVID-19 after adjusting for demographics and comorbidities in diabetic patients. Assessing the association between obesity and COVID-19 severity using the qSOFA score, the CURB-65 score, ICU admission, and mechanical ventilation at any point were our secondary endpoints.

The qSOFA score is a validated ICU mortality prediction score. It helps clinicians identify patients with suspected infections that are at high risk for poor outcomes. 17 We calculated qSOFA by awarding one point each for the Glasgow Coma Scale < 15, RR ≥ 22, and systolic blood pressure (SBP) ≤ 100. A qSOFA score ≥ 2 was used as the cutoff based on a higher risk of mortality. 18 The CURB-65 score was used to evaluate pneumonia severity. 19 It classifies mortality risk for pneumonia patients. 20 

For statistical analysis, IBM SPSS version 25 (IBM Corp., Armonk, NY, USA) was used. The normality of the data distribution was analyzed by the Kolmogorov-Smirnov test. The quantitative and qualitative values are reported as the mean and frequency (%), respectively. To compare data between obese and non-obese patients, we used the independent test. Between-group comparisons for qualitative data were performed by the chi-square test. Logistic regression was used to analyze univariate and multivariate models. The multivariate model considered demographic, lifestyle, and on-admission clinical factors significant in the univariate model. We adjusted the multivariate model for age, sex, smoking, and comorbidities. For all analyses, a P-value < 0.05 was considered significant.

The data of 317 diabetic COVID-19 patients were included in the present study. Table 1 shows demographic characteristics and comorbidity prevalence stratified by obesity status. The partici-pants' mean age was 65.09 ± 13.29 years and 51.4% was male.

There were significant differences between obese and non-obese participants regarding sex (P< 0.01). Table 2 presents outcome according to BMI. There were no significant differences between obese and non-obese patients regarding the frequency of death, mechanical ventilation, ICU admission, CURB-65 score, or qSOFA score. Table 3 summarizes the COV-ID-19 outcomes and obesity status logistic regression analyses.

There was no significant association between obesity and COV-ID-19 outcome in the unadjusted model. However, after adjusting for confounding factors (age, sex, smoking, and comorbidities), obese diabetic COVID-19 patients had a 2.72 times higher death rate than non-obese patients. Moreover, ventilator dependence were significantly higher in obese patients than non-obese patients.

Our study shows that mortality, ICU admission, and mechanical ventilation odds for hospitalized diabetic COVID-19 patients are significantly higher for obese patients than non-obese patients.

Obesity is a risk factor for severe COVID-19. 23 In Iran, obesity is a community health problem affecting 24% of the Iranian population. 24 Various studies have shown a significant association between obesity and poor COVID-19 outcomes. 23, 25, 26 In a systematic review, Földi et al. 25 reported that obesity is a significant risk factor for COVID-19 ICU admission and invasive mechanical ventilation.

Another systematic review and meta-analysis showed the dose-response association between BMI and COVID-19 mortality and severity. 27 Our results are likely related to the negative effect of both obesity and diabetes mellitus on immune function, 28, 29 which can result in poor COVID-19 outcomes. The higher inflammatory factors found in both obese and diabetic patients may make them susceptible to poor COVID-19 outcomes. 13 Obesity causes systemic inflammation 30 and diabetes mellitus is associated with low-grade chronic systemic inflammation. 31, 32 These two conditions may synergically affect COVID-19 outcomes. 33, 34 A cytokine storm immune response may cause multiorgan failure. 3 Lung mechanics may also play a significant role in the link between obesity and CO-VID-19 outcomes in diabetic patients. Earlier studies indicate that obesity is associated with poor mechanical ventilation due to limiting diaphragm and chest wall movement. 35, 36 Diabetes mellitus also affects lung function. 14, 15 These two comorbid conditions (obesity and diabetes mellitus) could result in impaired lung function.

Moreover, both obesity and diabetes mellitus are associated with increased plasminogen activator inhibitor-1 levels, which increases COVID-19 virulence, 16, 37 and increased reactive oxygen species levels and hypoxia-inducible factor 1α activation, which sustains severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication. 13, [38] [39] [40] 

Coronavirus update

Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review

Proper management of people with obesity during the COVID-19 pandemic

Characteristics and mortality of hospitalized patients with COVID-19 in Iran: a national retrospective cohort study

Average mortality rate of COVID-19 in Iran

Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China

Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis

Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome

clinical characteristics and risk factors for mortality of COVID-19 patients with diabetes in Wuhan, China: a two-center, retrospective study

Obesity and pneumonia: a complex relationship

Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: a systematic review and metaanalysis

Body mass index and the risk of COVID-19 across ethnic groups: analysis of UK Biobank

COVID-19 and diabetes mellitus: from pathophysiology to clinical management

Glycemic control and cardiopulmonary function in patients with insulin-dependent diabetes mellitus

Relationship between diabetes control and pulmonary function in insulin-dependent diabetes mellitus

Plasminogen activator inhibitor-1 and type 2 diabetes: a systematic review and metaanalysis of observational studies

qSO-FA as predictor of mortality and prolonged ICU admission in emergency department patients with suspected infection

Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (Sepsis-3)

Use of the 'CURB 65' score in hospital practice

Validation of predictive rules and indices of severity for community acquired pneumonia

Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia

Predicting early mortality in acute exacerbation of chronic obstructive pulmonary disease using the CURB65 score

Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality

Prevalence and associated factors of overweight or obesity and abdominal obesity in Iranian population: a population-based study of northwestern Iran

Obesity is a risk factor for developing critical condition in COVID-19 patients: a systematic review and meta-analysis

Obesity aggravates COVID-19: a systematic review and meta-analysis

Body mass index and outcome in patients with CO-VID-19: a dose-response meta-analysis

Obesity-related immunodeficiency in patients with pandemic influenza H1N1

Obesity and the outcome of infection

Obesity, systemic inflammation, and increased risk for cardiovascular disease and diabetes among adolescents: a need for screening tools to target interventions

The epidemiology of low-grade chronic systemic inflammation and type 2 diabetes

Cytokine secretion in long-standing diabetes mellitus type 1 and 2: associations with low-grade systemic inflammation

From COPD to chronic systemic inflammatory syndrome?

Systemic inflammation in chronic obstructive pulmonary disease and asthma: relation with comorbidities

The effect of obesity on lung function

ARDS in obese patients: specificities and management

Does obesity affect the plasma level of plasminogen activator inhibitor-1? And does CO2 pneumoperitoneum affect it?

Elevated glucose levels favor SARS-CoV-2 infection and monocyte response through a HIF-1α/glycolysis-dependent axis

Regulation of obesity and insulin resistance by hypoxia-inducible factors

Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes